-
Senate Majority Leader Chuck Schumer, D-NY, has accused a federal district court that spans North Texas and the Panhandle of assigning cases in a way that allows cases filed in certain areas to consistently land in front of judges who may be sympathetic to a plaintiff or defendant's goals.
-
At issue is the FDA's regulatory power to approve drugs and continually evaluate their safety — a system that until now has been widely viewed as the gold standard for both safety and innovation
-
A Texas federal judge revoked FDA approval of the self-managed abortion drug in April.
-
The Supreme Court has left the case in the hands of the 5th U.S. Circuit Court of Appeals, which has scheduled oral arguments in the case for May 17.
-
Supreme Court Justice Samuel Alito has placed a hold on a lower court ruling that restricts access to the abortion drug mifepristone until Wednesday night.
-
A Texas federal judge revoked long-standing FDA approval of a drug used to self-manage abortions and miscarriages. Abortion rights supporters say that will have wide-ranging repercussions for Texans, who already face extreme barriers to accessing reproductive care.